Reference : Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in lo...
Scientific journals : Article
Human health sciences : Gastroenterology & hepatology
http://hdl.handle.net/2268/111361
Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study.
English
Marechal, R. [> > > >]
Vos, B. [> > > >]
POLUS, Marc mailto [Centre Hospitalier Universitaire de Liège - CHU > > Gastro-Entérologie-Hépatologie]
Delaunoit, T. [> > > >]
Peeters, M. [Universitair Ziekenhuis Gent - UZ > Gastroenterology > > >]
Demetter, P. [> > > >]
Hendlisz, A. [> > > >]
Demols, A. [> > > >]
Franchimont, D. [> > > >]
VERSET, Gontran [Centre Hospitalier Universitaire de Liège - CHU > > Gastro-Entérologie-Hépatologie]
Van Houtte, P. [> > > >]
Van de Stadt, J. [> > > >]
Van Laethem, J. L. [> > > >]
Jun-2012
Annals of Oncology
Oxford University Press
23
6
1525-30
Yes (verified by ORBi)
International
0923-7534
1569-8041
London
United Kingdom
[en] BACKGROUND: Induction chemotherapy has been suggested to impact on preoperative chemoradiation efficacy in locally advanced rectal cancer (LARC). To evaluate in LARC patients, the feasibility and efficacy of a short intense course of induction oxaliplatin before preoperative chemoradiotherapy (CRT). PATIENTS AND METHODS: Patients with T2-T4/N+ rectal adenocarcinoma were randomly assigned to arm A-preoperative CRT with 5-fluorouracil (5-FU) continuous infusion followed by surgery-or arm B-induction oxaliplatin, folinic acid and 5-FU followed by CRT and surgery. The primary end point was the rate of ypT0-1N0 stage achievement. RESULTS: Fifty seven patients were randomly assigned (arm A/B: 29/28) and evaluated for planned interim analysis. On an intention-to-treat basis, the ypT0-1N0 rate for arms A and B were 34.5% (95% CI: 17.2% to 51.8%) and 32.1% (95% CI: 14.8% to 49.4%), respectively, and the study therefore was closed prematurely for futility. There were no statistically significant differences in other end points including pathological complete response, tumor regression and sphincter preservation. Completion of the preoperative CRT sequence was similar in both groups. Grade 3/4 toxicity was significantly higher in arm B. CONCLUSIONS: Short intense induction oxaliplatin is feasible in LARC patients without compromising the preoperative CRT completion, although the current analysis does not indicate increased locoregional impact on standard therapy.
http://hdl.handle.net/2268/111361
10.1093/annonc/mdr473

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
2012 MP-Short course chemotherapy...rectal cancer... phase II study-AnnOnc-PostPE epub 2011.pdfPublisher postprint113.59 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.